Lauren Moran

1.4k total citations
5 papers, 424 citations indexed

About

Lauren Moran is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Lauren Moran has authored 5 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Lauren Moran's work include Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Lauren Moran is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Lauren Moran collaborates with scholars based in United States. Lauren Moran's co-authors include Victor M. Rivera, Tim Clackson, Frank Wang, Scott Wardwell, Narayana I. Narasimhan, Qurish K. Mohemmad, William C. Shakespeare, Matthew J. Wong, Joseph M. Gozgit and David F. Miller and has published in prestigious journals such as Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Lauren Moran

5 papers receiving 419 citations

Peers

Countries citing papers authored by Lauren Moran

Since Specialization

Citations

This map shows the geographic impact of Lauren Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Moran more than expected).

Fields of papers citing papers by Lauren Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Moran. The network helps show where Lauren Moran may publish in the future.

Co-authorship network of co-authors of Lauren Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Moran. A scholar is included among the top collaborators of Lauren Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Moran. Lauren Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Abstract 5655: AP26113 possesses pan-inhibitory activity versus crizotinib-resistant ALK mutants and oncogenic ROS1 fusions. 2013 ·Cancer Research ·Rachel M. Squillace, Rana Anjum, David F. Miller, Sadanand Vodala, Lauren Moran, Frank Wang, Tim Clackson, Andrew P. Garner, Victor M. Rivera	31
2	Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models 2012 ·Molecular Cancer Therapeutics ·Joseph M. Gozgit, Matthew J. Wong, Lauren Moran, Scott Wardwell, Qurish K. Mohemmad, Narayana I. Narasimhan, William C. Shakespeare, Frank Wang, Tim Clackson, Victor M. Rivera	273
3	Abstract 1794: AP26113 is a dual ALK/EGFR inhibitor: Characterization against EGFR T790M in cell and mouse models of NSCLC 2012 ·Cancer Research ·Victor M. Rivera, Frank Wang, Rana Anjum, Sen Zhang, Rachel M. Squillace, Jeffrey Keats, David F. Miller, Yaoyu Ning, Scott Wardwell, Lauren Moran, Juan J. Miret, Narayana I. Narasimhan, David C. Dalgarno, Tim Clackson, (unknown)	36
4	Antitumor Activity of Ridaforolimus and Potential Cell-Cycle Determinants of Sensitivity in Sarcoma and Endometrial Cancer Models 2011 ·Molecular Cancer Therapeutics ·Rachel M. Squillace, David F. Miller, (unknown), Scott Wardwell, Lauren Moran, David E. Clapham, Frank Wang, Tim Clackson, Victor M. Rivera	40
5	Abstract LB-298: AP26113, a potent ALK inhibitor, overcomes mutations in EML4-ALK that confer resistance to PF-02341066 (PF1066) 2010 ·Cancer Research ·Sen Zhang, Frank Wang, Jeffrey Keats, Yaoyu Ning, Scott Wardwell, Lauren Moran, Qurish K. Mohemmad, Rana Anjum, Yihan Wang, Xiaotian Zhu, Juan J. Miret, David C. Dalgarno, Narayana I. Narasimhan, Tim Clackson, William C. Shakespeare, Victor M. Rivera	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact